Repetition of serotonin syndrome after reexposure to SSRI - A case report

被引:10
作者
Tomaselli, G [1 ]
Modestin, J [1 ]
机构
[1] Psychiat Univ Hosp Zurich, CH-8029 Zurich, Switzerland
关键词
D O I
10.1055/s-2004-832598
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We describe here the occurrence of a serotonin syndrome (SS) in a 64-year-old depressed female patient with alcoholic hepatic cirrhosis after treatment with SSRIs. Two weeks after the increase of the dosage of sertraline, the patient developed a fullblown SS, which resolved completely after the discontinuation of the drug. The therapy with citalopram led again to development of milder SS, this time immediately after the increase of the dosage. Our case illustrates the variability of the clinical presentation and the temporal evolution of SS in a patient with preexisting medical illness affecting hepatic metabolism. Reexposure of patients with a history of SS to another serotoninergic drug should be avoided; if necessary, it must be carried out with the utmost caution.
引用
收藏
页码:236 / 238
页数:3
相关论文
共 16 条
[1]   Paroxetine associated hepatotoxicity: A report of 3 cases and a review of the literature [J].
Azaz-Livshits, T ;
Hershko, A ;
Ben-Chetrit, E .
PHARMACOPSYCHIATRY, 2002, 35 (03) :112-115
[2]   Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors [J].
Baumann, P .
CLINICAL PHARMACOKINETICS, 1996, 31 (06) :444-469
[3]   Neuroleptic malignant syndrome due to atypical neuroleptics:: Three episodes in one patient [J].
Bottlender, R ;
Jäger, M ;
Hofschuster, E ;
Dobmeier, P ;
Möller, HJ .
PHARMACOPSYCHIATRY, 2002, 35 (03) :119-121
[4]   Pathophysiology and management of the serotonin syndrome [J].
Brown, TM ;
Skop, BP ;
Mareth, TR .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) :527-533
[5]   Influence of liver cirrhosis on sertraline pharmacokinetics [J].
Demolis, JL ;
Angebaud, P ;
Grange, JD ;
Coates, P ;
FunckBrentano, C ;
Jaillon, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) :394-397
[6]   TOXIC SEROTONIN SYNDROME OR ESTRAPYRAMIDAL SIDE-EFFECTS [J].
DURSUN, SM ;
BURKE, JG ;
REVELEY, MA .
BRITISH JOURNAL OF PSYCHIATRY, 1995, 166 :401-402
[7]   The serotonin syndrome scale: first results on validity [J].
Hegerl, U ;
Bottlender, R ;
Gallinat, J ;
Kuss, HJ ;
Ackenheil, M ;
Moller, HJ .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1998, 248 (02) :96-103
[8]   The serotonin syndrome: investigation using the Japanese version of the Serotonin Syndrome Scale [J].
Kaneda, Y ;
Ohmori, T ;
Fujii, A .
PSYCHIATRY RESEARCH, 2001, 105 (1-2) :135-142
[9]   THE PHARMACOKINETICS OF PAROXETINE IN PATIENTS WITH LIVER-CIRRHOSIS [J].
KRASTEV, Z ;
TERZIIVANOV, D ;
VLAHOV, V ;
MALEEV, A ;
GREB, WH ;
ECKL, KM ;
DIERDORF, HD ;
WOLF, D .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 :91-92
[10]   Serotonin syndrome during clomipramine monotherapy: Comparison of two diagnostic criteria [J].
Kudo, K ;
Sasaki, I ;
Tsuchiyama, K ;
Akiyoshi, J ;
Nagayama, H ;
Fujii, I .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1997, 51 (01) :43-46